Status:
COMPLETED
Little Cigar and Cigarillo Warnings to Reduce Tobacco-Related Cancers and Disease - Eye Tracking
Lead Sponsor:
UNC Lineberger Comprehensive Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Food and Drug Administration (FDA)
Conditions:
Tobacco Use
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The goal of this research is to determine how removal of little cigar and cigarillo (LCC) flavor descriptors on packaging impacts attention and affective responses to LCC warnings. A study will be con...
Detailed Description
Over 4 million US adults regularly smoke cigars, which causes multiple cancers, including oral, esophageal, pancreatic, laryngeal, and lung cancer. Even smoking 1-2 cigars per day is associated with e...
Eligibility Criteria
Inclusion
- Participants will be recruited through flyers, emails, and recruitment websites to identify potentially eligible participants local to our study location (Chapel Hill/Carrboro, NC)
- Over 21 years old
- Pass quality/bot screening (will answer honestly, captcha, simple math question)
- Speak English
- Current every day or some day users of LCC products
- Able to come to an appointment in NC triangle area
- Do not have any eye conditions that prevent them from being eye tracked (e.g., glaucoma, lazy eye, bifocals)
Exclusion
- Under 21 years old
- Do not speak English
- Unable to pass quality/bot screening
- Unable to come to an appointment
- Eye conditions that prevent eye tracking (e.g., glaucoma, lazy eye, bifocals)
Key Trial Info
Start Date :
August 14 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 5 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06546618
Start Date
August 14 2024
End Date
March 5 2025
Last Update
September 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27599